The CardioMetabolic Profile - Blood Spot from ZRT Laboratory tests for several key biomarkers associated with cardiometabolic health:
 
CardioMetabolic Profile | ZRT Labs
Assesses risks associated with type 2 diabetes and cardiovascular disease. Tests in this profile include: Insulin, high sensitivity C-Reactive Protein, Hemoglobin A1c, Triglycerides.*
Blood Spot: In, hsCRP, HbA1c, TG, CH, HDL, LDL, VLDL
 
Glucose: Measurement of fasting glucose levels is a crucial first step in assessing insulin resistance and diabetes risk. Elevated fasting glucose is a significant risk factor for cardiovascular disease (CVD) and type 2 diabetes.  [5.]
Hemoglobin A1c (HbA1c): HbA1c provides a measure of long-term blood sugar control, reflecting average blood glucose levels over the past 2-3 months. Elevated HbA1c levels are indicative of poor glycemic control and increased risk of CVD and diabetes.  [12.]
Insulin: elevated insulin levels indicate insulin resistance, a key driver of metabolic syndrome and type 2 diabetes. Elevated fasting insulin levels are associated with dyslipidemia, hypertension, and obesity, all contributing factors to CVD risk.  [5.]  A fasting insulin level also provides a much more comprehensive picture of overall blood sugar control than glucose and HbA1c alone, and can point to blood sugar dysregulation long before HbA1c levels rise.  [8., 11.]
Lipids (Total Cholesterol, LDL Cholesterol, VLDL Cholesterol, HDL Cholesterol, Triglycerides): Lipid profile assessment is essential for evaluating cardiovascular risk. Elevated LDL and VLDL cholesterol and triglyceride levels, along with low HDL cholesterol, are key components of dyslipidemia and contribute to atherosclerosis and CVD development.  [8.]  Dyslipidemia in the setting of insulin resistance can cause or worsen non-alcoholic fatty liver disease, or NAFLD.  
C-Reactive Protein, High Sensitivity (hs-CRP): hs-CRP is a marker of systemic endothelial inflammation and predicts cardiovascular events independent of traditional risk factors. Because hs-CRP correlates with inflammation at the level of the endothelium, or the inner lining of blood vessels, elevated hs-CRP levels are associated with increased risk of CVD and can guide preventive interventions.  [10.]
Including these biomarkers in the CardioMetabolic Profile - Blood Spot test allows for comprehensive assessment of cardiometabolic health and enables early intervention to mitigate associated risks.
Who Might Benefit From This Test?
Individuals With a Family History of Cardiometabolic Conditions: people with a family history of cardiometabolic conditions including obesity, hypertension, dyslipidemia, insulin resistance, metabolic syndrome, cardiovascular disease (CVD) or diabetes can all benefit from the insights provided by the CardioMetabolic Profile - Blood Spot from ZRT Laboratory Test.  Many of these conditions are driven by genetic factors, and disease progression may occur for years before clinically apparent signs or symptoms manifest.  [4.]
Individuals at Risk of Developing Cardiometabolic Conditions: in addition to having a family history of cardiometabolic conditions, many lifestyle factors are implicated in disease progression.  These include eating a [standard American diet], high sugar and carbohydrate intake, smoking, excessive alcohol consumption, a sedentary lifestyle, and inadequate restful sleep.  [13.]
Individuals who have been diagnosed with a cardiometabolic condition: being diagnosed with a cardiometabolic condition often inspires diet and lifestyle changes in individuals.  The CardioMetabolic Profile - Blood Spot from ZRT Laboratory is an effective tool to monitor objective changes in a person’s health profile in response to such changes.  [1.]  It can also monitor disease progression and alert the clinician to the need to increase therapeutic interventions.  
People interested in optimizing their health and wellness: The CardioMetabolic Profile - Blood Spot from ZRT Laboratory is an effective screening tool for anyone interested in optimizing their health and wellness.  Using a simple blood spot sample, it provides comprehensive insights into key biomarkers associated with cardiometabolic health including fasting glucose and insulin, lipids, and hs-CRP, enabling early detection of cardiometabolic risk factors and allowing individuals to take proactive steps to improve their health.